Ratings by B.Riley (Mayank Mamtani)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Theravance Biopharma | TBPH | Downgrade | Neutral (Buy) |
18.95 (13.57) |
-28.39% | Details | |
| 2/23/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2026 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Opus Genetics | IRD | New Coverage | Buy (N/A) |
2.29 (4.89) |
113.54% | Details | |
| 12/1/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2025 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Cognition Therapeutics | CGTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2025 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
4.67 (4.59) |
-1.71% | Details | |
| 11/10/2025 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2025 | Zymeworks | ZYME | New Coverage | Buy (N/A) |
16.68 (24.08) |
44.36% | Details | |
| 10/1/2025 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2025 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2025 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2025 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2025 | Theravance Biopharma | TBPH | New Coverage | Buy (N/A) |
13.64 (18.95) |
38.93% | Details | |
| 8/26/2025 | Actuate Therapeutics | ACTU | New Coverage | Buy (N/A) |
8.36 (2.86) |
-65.79% | Details | |
| 8/14/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
12.57 (22.07) |
75.58% | Details | |
| 5/21/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2025 | MacroGenics | MGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2025 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2025 | Vaxart Inc. | VXRT | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Madrigal Pharmaceuticals | MDGL | Upgrade | Buy (Neutral) |
355.88 (432.83) |
21.62% | Details | |
| 2/7/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Cognition Therapeutics | CGTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Nektar Therapeutics | NKTR | New Coverage | Buy (N/A) |
1.17 (70.70) |
5942.74% | Details | |
| 12/19/2024 | Cognition Therapeutics | CGTX | Upgrade | Buy (Neutral) |
0.58 (1.03) |
77.59% | Details | |
| 11/25/2024 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2024 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
51.53 (32.98) |
-36% | Details | |
| 11/18/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2024 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Gritstone bio | GRTS | Downgrade | Neutral (Buy) |
0.58 (0.03) |
-94.83% | Details | |
| 8/8/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Cognition Therapeutics | CGTX | Downgrade | Neutral (Buy) |
0.66 (1.03) |
56.06% | Details | |
| 8/2/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2024 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
5.47 (2.23) |
-59.23% | Details | |
| 6/14/2024 | Vaxart Inc. | VXRT | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2024 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2024 | Gritstone bio | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 4/26/2024 | MacroGenics | MGNX | New Coverage | Buy (N/A) |
15.70 (5.47) |
-65.16% | Details | |
| 3/28/2024 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Upgrade | Neutral (Sell) |
272.98 (432.83) |
58.56% | Details | |
| 2/26/2024 | Madrigal Pharmaceuticals | MDGL | Downgrade | Sell (Neutral) |
236.54 (432.83) |
82.98% | Details | |
| 2/23/2024 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2024 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Buy) |
25.69 (32.48) |
26.43% | Details | |
| 2/5/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2024 | Vaxart Inc. | VXRT | Upgrade | Buy (Neutral) |
0.98 (0.32) |
-67.35% | Details | |
| 1/8/2024 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | Gritstone Oncology | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
36.32 (60.41) |
66.33% | Details | |
| 10/20/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2023 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.94 (8.48) |
337.11% | Details | |
| 10/10/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 9/8/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Novavax | NVAX | Upgrade | Buy (Neutral) |
7.23 (9.98) |
38.04% | Details | |
| 8/3/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2023 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Gritstone Oncology | GRTS | New Coverage | Buy (N/A) |
2.47 (0.03) |
-98.79% | Details | |
| 3/1/2023 | Novavax | NVAX | Downgrade | Neutral (Buy) |
9.26 (9.98) |
7.78% | Details | |
| 2/17/2023 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2023 | Cassava Sciences | SAVA | Maintain | Neutral (N/A) |
|
Details | ||
| 1/9/2023 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2022 | Vaxart Inc. | VXRT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/16/2022 | Spectrum Pharmaceuticals | SPPI | Downgrade | Neutral (Buy) |
0.52 (1.03) |
98.08% | Details | |
| 11/10/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2022 | Gain Therapeutics | GANX | Downgrade | Neutral (Buy) |
3.95 (3.05) |
-22.78% | Details | |
| 8/11/2022 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2022 | Madrigal Pharmaceuticals | MDGL | Downgrade | Neutral (Buy) |
76.62 (432.83) |
464.9% | Details | |
| 6/14/2022 | Lineage Cell Therapeutics Inc. | LCTX | New Coverage | Buy (N/A) |
1.30 (1.85) |
42.31% | Details | |
| 6/13/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2022 | Vaxart Inc. | VXRT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/19/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2022 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2022 | Allena Pharmaceuticals | ALNA | Downgrade | Neutral (Buy) |
0.48 (0.08) |
-83.33% | Details | |
| 3/18/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2022 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | Seelos Therapeutics | SEEL | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2022 | Seelos Therapeutics | SEEL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Vaxart Inc. | VXRT | New Coverage | Neutral (N/A) |
4.69 (0.32) |
-93.18% | Details | |
| 3/1/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Eloxx Pharma | ELOX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2021 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
21.28 (38.22) |
79.61% | Details | |
| 11/3/2021 | Gain Therapeutics | GANX | New Coverage | Buy (N/A) |
7.04 (3.05) |
-56.68% | Details | |
| 9/22/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
| 8/10/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2021 | Vaxart Inc. | VXRT | Downgrade | Neutral (Buy) |
8.73 (0.32) |
-96.33% | Details | |
| 6/23/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2021 | Eloxx Pharma | ELOX | New Coverage | Buy (N/A) |
1.39 (0.00) |
-100% | Details | |
| 5/17/2021 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2021 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Arcturus Therapeutics | ARCT | Downgrade | Sell (Neutral) |
68.94 (7.11) |
-89.69% | Details | |
| 2/8/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2020 | Heat Biologics | HTBX | New Coverage | Buy (N/A) |
5.85 (2.83) |
-51.62% | Details | |
| 12/11/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2020 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2020 | Galmed Pharmaceuticals | GLMD | Downgrade | Neutral (Buy) |
6.08 (0.66) |
-89.14% | Details | |
| 5/22/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | CymaBay Therapeutic | CBAY | Upgrade | Buy (Neutral) |
1.84 (32.48) |
1665.22% | Details | |
| 5/12/2020 | Genfit SA | GNFT | Downgrade | Neutral (Buy) |
22.00 (4.85) |
-77.95% | Details | |
| 4/3/2020 | Galectin Therapeutics | GALT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2020 | CymaBay Therapeutic | CBAY | Maintain | Neutral (N/A) |
|
Details | ||
| 3/18/2020 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2020 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2019 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2019 | ArQule | ARQL | Downgrade | Neutral (Buy) |
9.67 (20.00) |
106.83% | Details | |
| 12/9/2019 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2019 | Spectrum Pharmaceuticals | SPPI | New Coverage | Buy (N/A) |
8.78 (1.03) |
-88.27% | Details | |
| 11/27/2019 | ArQule | ARQL | New Coverage | Buy (N/A) |
8.99 (9.67) |
7.56% | Details | |
| 11/27/2019 | TG Therapeutics | TGTX | New Coverage | Buy (N/A) |
7.50 (29.27) |
290.27% | Details | |
| 11/19/2019 | Agenus Inc. | AGEN | New Coverage | Buy (N/A) |
4.40 (2.95) |
-32.95% | Details | |
| 11/14/2019 | Galectin Therapeutics | GALT | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2019 | Genfit | GNFT | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | CymaBay Therapeutic | CBAY | Maintain | Neutral (N/A) |
|
Details | ||
| 6/10/2019 | Madrigal Pharmaceuticals | MDGL | Upgrade | Buy (Neutral) |
91.13 (432.83) |
374.96% | Details | |
| 5/28/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | CymaBay Therapeutic | CBAY | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2019 | Galectin Therapeutics | GALT | New Coverage | Buy (N/A) |
4.14 (3.10) |
-25.12% | Details | |
| 2/6/2019 | CymaBay Therapeutic | CBAY | New Coverage | Neutral (N/A) |
8.92 (1.84) |
-79.37% | Details | |
| 12/21/2018 | Allena Pharmaceuticals | ALNA | New Coverage | Buy (N/A) |
5.36 (0.48) |
-91.04% | Details | |
| 12/12/2018 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
9.46 (51.53) |
444.71% | Details | |
| 12/12/2018 | Madrigal Pharmaceuticals | MDGL | New Coverage | Neutral (N/A) |
112.89 (91.13) |
-19.28% | Details | |
| 12/12/2018 | Intercept Pharmaceuticals | ICPT | New Coverage | Buy (N/A) |
105.99 (19.00) |
-82.07% | Details | |
| 12/12/2018 | Galmed Pharmaceuticals | GLMD | New Coverage | Buy (N/A) |
8.37 (0.66) |
-92.11% | Details |
